Skip to main content
Clinical Trials/NCT02422407
NCT02422407
Completed
N/A

A Biomarker Study to Determine the Gene Expression Signatures of Salivary Gland and Blood in Subjects With Incident Primary Sjögren's Syndrome, Subjects With Sicca, and Healthy Volunteers

Biogen1 site in 1 country100 target enrollmentMarch 26, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Healthy
Sponsor
Biogen
Enrollment
100
Locations
1
Primary Endpoint
Gene expression levels in immune cells (innate and adaptive) in salivary gland biopsy samples from participants with and without pSS including healthy volunteers
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The main objective of the study is to characterize the gene expression in immune and epithelial cells in salivary gland biopsy samples and blood of pSS (primary Sjögren's syndrome) and non-pSS participants including healthy volunteers.

Registry
clinicaltrials.gov
Start Date
March 26, 2015
End Date
August 22, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Biogen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • For Healthy Volunteers:
  • In good overall health as determined by the Investigator For Participants With Sicca
  • Subjects should present with sicca (i.e., dry eyes and dry mouth) at Baseline
  • Must be willing to undergo a minor salivary gland (labial) biopsy

Exclusion Criteria

  • A history of any clinically significant medical condition, as determined by the Investigator, that may impact study analyses
  • A chronic or persistent infection human immunodeficiency virus (HIV), hepatitis B, hepatitis C, and/or tuberculosis
  • Pre-existing connective tissue disease or autoimmune disease, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, systemic sclerosis, or sarcoidosis
  • Any known contraindications of sialoscintigraphy
  • NOTE: Other protocol defined Inclusion/Exclusion criteria may apply

Outcomes

Primary Outcomes

Gene expression levels in immune cells (innate and adaptive) in salivary gland biopsy samples from participants with and without pSS including healthy volunteers

Time Frame: Up to 12 months

Gene expression levels in immune cells (innate and adaptive) in blood samples from participants with and without pSS including healthy volunteers

Time Frame: Up to 12 months

Gene expression levels in epithelial cells in salivary gland biopsy samples from participants with and without pSS including healthy volunteers

Time Frame: Up to 12 months

Gene expression levels in epithelial cells in blood samples from participants with and without pSS including healthy volunteers

Time Frame: Up to 12 months

Study Sites (1)

Loading locations...

Similar Trials